| Chilkoti, Ashutosh |
Duke University
United States |
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer |
5UH3CA211232-05 |
|
Jo Ann Rinaudo, Ph.D. |
| Buelow, Hannes Erich |
Albert Einstein College Of Medicine
United States |
A Fluorescence-Based High-Throughput Platform for Glycotyping the Hematopoietic Cell Lineage |
5U01CA241981-03 |
|
Guillermo Marquez, Ph.D. |
| Vigneron, Daniel B |
University Of California, San Francisco
United States |
Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients |
5U01CA232320-04 |
PAR-16-089 (U01) |
Richard Mazurchuk, Ph.D. |
| Li, Wenyuan |
University Of California Los Angeles
United States |
Informatics resources for liquid biopsy research |
5U01CA237711-03 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Shu, Xiao-Ou |
Vanderbilt University Medical Center
United States |
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer |
5R01CA227133-05 |
|
Matthew Young, Ph.D. |
| Rohan, Thomas E |
Albert Einstein College Of Medicine
United States |
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ |
5R01CA218429-06 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Schnaar, Ronald L |
Johns Hopkins University
United States |
Ganglioside interactome toolkit |
5U01CA241953-03 |
|
Guillermo Marquez, Ph.D. |
| Cocucci, Emanuele |
Ohio State University
United States |
A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL |
1R01CA270251-01A1 |
PAR-20-053 (R01 Clinical Trial Not Allowed) |
Matthew Young, Ph.D. |
| Khush, Kiran Kaur |
Stanford University
United States |
A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation |
5R01CA229766-05 |
|
|
| Drake, Richard R. |
Medical University Of South Carolina
United States |
Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids |
5R33CA267226-02 |
RFA-CA-21-004 (R33 Clinical Trial Not Allowed) |
|